Role of HIV membrane in neutralization by two broadly neutralizing antibodies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.0908713106PMID 19906992PMCID PMC2787149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viral membrane fusion

  2008cited by this paper
• The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design

  2008cited by this paper
• The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design

  2008cited by this paper
• A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

  2008influential reference
• The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes1

  2007influential reference
• Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion.

  2007cited by this paper
• Simian Immunodeficiency Virus Engrafted with Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Epitopes: Replication, Neutralization, and Survey of HIV-1-Positive Plasma

  2006cited by this paper
• The HIV lipidome: a raft with an unusual composition.

  2006influential reference
• Membrane Association and Epitope Recognition by HIV-1 Neutralizing Anti-gp41 2F5 and 4E10 Antibodies

  2006cited by this paper
• A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.

  2006influential reference
• Monoclonal Antibodies to Phosphatidylinositol Phosphate Neutralize Human Immunodeficiency Virus Type 1: Role of Phosphate-Binding Subsites

  2006cited by this paper
• Proteomic and Biochemical Analysis of Purified Human Immunodeficiency Virus Type 1 Produced from Infected Monocyte-Derived Macrophages

  2006cited by this paper
• The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20.

  2005cited by this paper
• Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.

  2005cited by this paper
• Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

  2005cited by this paper
• Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope

  2004influential reference
• The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5

  2004cited by this paper
• Evaluation of the Safety, Immunogenicity, and Protective Efficacy of Whole Inactivated Simian Immunodeficiency Virus (SIV) Vaccines with Conformationally and Functionally Intact Envelope Glycoproteins

  2004cited by this paper
• Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes

  2004cited by this paper
• Rapid evolution of the neutralizing antibody response to HIV type 1 infection

  2003cited by this paper
• Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.

  2003cited by this paper
• A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.

  2002cited by this paper
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

  2002cited by this paper
• Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro

  2002cited by this paper
• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins

  1998cited by this paper
• HIV entry and its inhibition.

  1998cited by this paper
• Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41

  1998cited by this paper
• Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.

  1997cited by this paper
• Core structure of gp41 from the HIV envelope glycoprotein.

  1997cited by this paper
• Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.

  1997cited by this paper
• Atomic structure of the ectodomain from HIV-1 gp41

  1997cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

  1994cited by this paper
• A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

  1993cited by this paper

• Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection

  2026cites this paper
• Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines

  2026cites this paper
• Conformational Variability of HIV-1 Env Trimer and Viral Vulnerability

  2025cites this paper
• Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.

  2025cites this paper
• Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines

  2025cites this paper
• Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes.

  2025cites this paper
• Probing the role of membrane in neutralizing activity of antibodies against influenza virus.

  2025cites this paper
• Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations

  2024influential citation
• Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.

  2024cites this paper
• A two‐step mechanism for the binding of the HIV‐1 MPER epitope by the 10E8 antibody onto biosensor‐supported lipid bilayers

  2024cites this paper
• Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines

  2024cites this paper
• Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER).

  2024cites this paper
• Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis

  2023cites this paper
• Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility

  2023cites this paper
• Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development

  2023cites this paper
• Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility

  2023cites this paper
• Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review

  2023cites this paper
• Parameter estimation and identifiability analysis for a bivalent analyte model of monoclonal antibody-antigen binding

  2022cites this paper
• Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies

  2022cites this paper
• Functional Delineation of a Protein–Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8

  2022cites this paper
• Antibody multispecificity: A necessary evil?

  2022cites this paper
• Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies

  2022influential citation
• Enhancing HIV-1 neutralization by increasing the local concentration of MPER-directed bnAbs

  2022cites this paper
• Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile

  2021cites this paper
• HIV-1 Entry and Membrane Fusion Inhibitors

  2021cites this paper
• Neutralizing Antibodies Targeting HIV-1 gp41

  2020cites this paper
• Immune checkpoint modulation enhances HIV-1 antibody induction

  2020cites this paper
• A Universal CAR‐NK Cell Targeting Various Epitopes of HIV‐1 gp160

  2020cites this paper
• The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8

  2020cites this paper
• The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation

  2020cites this paper
• The conserved positive charge in the transmembrane domain of HIV gp41 contributes to its trimerization

  2020cites this paper
• The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

  2020cites this paper
• Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector

  2019influential citation
• Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state

  2019cites this paper
• HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

  2019cites this paper
• Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

  2019cites this paper
• VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design.

  2019cites this paper
• Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions

  2019cites this paper
• Identification of HIV-1 Envelope Mutations that Enhance Entry Using Macaque CD4 and CCR5

  2019cites this paper
• The Conserved Positive Charge in the Transmembrane Domain of HIV Gp41 Contributes to Its Intrinsic Preference for Trimerization

  2019cites this paper
• The Bilayer Collective Properties Govern the Interaction of an HIV-1 Antibody with the Viral Membrane.

  2019cites this paper
• Longitudinal Analysis Reveals Early Development of Three MPER‐Directed Neutralizing Antibody Lineages from an HIV‐1‐Infected Individual

  2019cites this paper
• Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

  2019cites this paper
• Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5

  2019cites this paper
• IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells

  2018cites this paper
• Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

  2018cites this paper
• Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions

  2018cites this paper
• The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects

  2018cites this paper
• Structure of the membrane proximal external region of HIV-1 envelope glycoprotein

  2018cites this paper
• Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77

  2018cites this paper
• Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies

  2018cites this paper
• Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity

  2018cites this paper
• Genetic and structural analyses of affinity maturation in the humoral response to HIV‐1

  2017cites this paper
• Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target

  2017influential citation
• Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.

  2017cites this paper
• A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles

  2017cites this paper
• Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

  2017cites this paper
• Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design

  2017cites this paper
• Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.

  2017cites this paper
• Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody*

  2017cites this paper
• Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein.

  2017cites this paper
• Human Ig knockin mice to study the development and regulation of HIV‐1 broadly neutralizing antibodies

  2017cites this paper
• Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization

  2017cites this paper
• Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane.

  2017cites this paper
• Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates

  2017cites this paper
• T cells control the generation of nanomolar-affinity anti-glycan antibodies

  2017cites this paper
• HIV induced suppression of host immunity: relevance to Mycobacterium tuberculosis infections

  2017cites this paper
• Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif

  2017cites this paper
• HIV-1 vaccine design: Learning from natural infection

  2016influential citation
• Trimerization of the HIV Transmembrane Domain in Lipid Bilayers Modulates Broadly Neutralizing Antibody Binding.

  2016cites this paper
• Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages

  2016cites this paper
• Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking

  2016cites this paper
• Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.

  2016influential citation
• Functional organization of the HIV lipid envelope

  2016cites this paper
• The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?

  2016cites this paper
• Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies.

  2016cites this paper
• Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins

  2016cites this paper
• Evolution of the Humoral Response during HCV Infection: Theories on the Origin of Broadly Neutralizing Antibodies and Implications for Vaccine Design.

  2016cites this paper
• Broad Neutralizing Antibodies to HIV Env and Other Complex Viral Antigens from Vaccinated Cows

  2016cites this paper
• Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env

  2016cites this paper
• Searching for an hiv vaccine: a heterologous prime-boost system using replicating vaccinia virus and plant-produced virus-like particles

  2016cites this paper
• Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.

  2016cites this paper
• Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity

  2016cites this paper
• Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.

  2016cites this paper
• Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

  2015cites this paper
• Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4 E 10

  2015cites this paper
• Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10

  2015cites this paper
• Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

  2015cites this paper
• Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein

  2015cites this paper
• Founder virus envelope glycoproteins as novel oligomeric HIV-1 vaccine immunogens

  2015cites this paper
• Discrete partitioning of HIV-1 Env forms revealed by viral capture

  2015cites this paper
• Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes.

  2015cites this paper
• Bound by the Antibody Dendritic Cells Is Dependent on the Epitope Reactivation of Neutralized HIV-1 by

  2015cites this paper
• The Cellular and Molecular Biology of HIV-1 Broadly Neutralizing Antibodies

  2015cites this paper
• Functionalization of Cobalt Porphyrin-Phospholipid Bilayers with His-tagged Ligands and Antigens

  2015cites this paper
• HIV-1 vaccine epitope delivery based on foamy viral hybrid proteins and vectors

  2015cites this paper
• Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

  2015cites this paper
• Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody

  2015cites this paper
• Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent

  2015cites this paper
• Natural and Induced Antibody Polyreactivity.

  2015cites this paper